Gene Therapy Trials Offering Hope for Hemophilic Patients

According to a new research report by RNCOS entitled, ?Global Gene Therapy Market Outlook 2020?, the advancement of gene therapy for hemophilia is likely to prove to be one of the hottest areas as well as one of the biggest markets for expensive biotech drugs. It is going to be the greatest medical advances in the coming years, as industry participants are increasingly strengthening the research-based approach to develop newer products for various life-threatening diseases.

Hemophilia is a monogenic disorder, whose treatment involves raising the levels of Factor VIII or Factor IX in patient?s blood to at least 5%, which can be effectively achieved through gene therapy by substituting faulty genes with new clotting (factor IX) genes. Citing the potential of gene therapy in treating hemophilia, various companies have initiated clinical trials for obtaining regulatory approval for hemophilia A and B. Gene therapy for hemophilia A possibly could be the biggest product for companies targeting it, says RNCOS. Spark therapeutics, Dimension therapeutics and hemophilia expert Baxter International are chasing hemophilia B. Companies are getting into various collaborations, joint ventures, for the advancement and potential commercialization of products & for developing gene therapies for hemophilia A and B. Such collaborations help the companies to explore new applications of the gene therapy market.

The report takes into account all the key aspects of the worldwide gene therapy market and projects the market during the period 2015-2020. It prudently analyzes all the industry segments in an effective manner by focusing on major players and products, recent developments, application support in terms of indications, geographical performance and last but not the least, current and future market size. Moreover, the report provides a brief summary of the recent trends that may have an impact on the future industry performance. Overall, the report will prove to be a complete source of knowledge and analysis for clients and potential investors.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM780.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.

Company :-RNCOS E-Services Pvt. Ltd.

User :- Shushmul Maheshwari

Email :-press@rncos.com

Phone :-91-120-4224700

Mobile:- -

Url :- http://www.rncos.com